Access to Innovation 2019 Agenda
Theme: ‘Innovating for Critical Mass’
*Please note the schedule is subject to change*
8.00 – 8.30 Registration, Continental Breakfast & Networking Sponsored by APS and Fasken
8.30 – 8.40 Welcome & Introduction
Nancy Harrison, Chair, Board of Directors, LifeSciences BC
8.40 – 8.45 Government of British Columbia Welcome
Dr. Alan Winter, B.C. Innovation Commissioner
8.45 – 9:15 Keynote: Learning Health Systems in Canada
Dr. Tom Noseworthy, CEO, BC Academic Health Sciences Network (BCAHSN)
9.15 – 9.20 Innovate BC – Morning Sponsor
William Johnson, Director, Marketing & Communications
9.20 – 10.15 Session 1: Healthcare Innovation Strategy
Sponsored By: AstraZeneca & CDRD
Moderator: Gordon McCauley, President & CEO, Centre for Drug Research & Development (CDRD)
Panellists:
- Karimah Es Sabar, Chair, Health Bioscience Economic Strategy Table (HBEST) & President & CEO, Quark Venture
- Neil Fraser, President, Medtronic
- Joyce Drohan, Partner, Omnia Artificial Intelligence BC Leader, Deloitte Canada
10.15 – 10.30 Session 2: New Patient-Care Discovery
Ohad Arazi, Chief Strategy Officer and Vice President, TELUS Health
10.30 – 11.00 Networking Break Sponsored By: AbCellera
11.00 – 12.00 Session 3: Public – Private Partnerships
Sponsored By: LifeLabs
11.00 – 11.15 Canada’s Digital Technology Supercluster: Program Development and Review
Bill Tam, Co-Founder, VP Business Development and Partnerships, Digital Technology Supercluster
11.15 – 11.30 Innovation for Defence Excellence and Security Program
Christopher Brosinsky, Director, Innovation for Defence Excellence and Security (IDEaS), Department of National Defence, Canadian Armed Forces
11.30 – 11.45 LifeLabs – Strategic Private Partnerships
Jennifer Cudlipp, Senior Vice President B.C., LifeLabs
11.45 – 12.00 GSK: Partnership Environment Building
Meg Ehm, Senior Scientific Director, Target Sciences Group, GSK
12.00 – 1.00 Lunch Sponsored By: CHÉOS
1.00 – 1.15 Centre for Health Evaluation & Outcome Sciences (CHÉOS)
Dr. Larry Lynd, Professor, Faculty of Medicine, Rare Diseases, University of British Columbia
1.15 – 1.30 Innovative Medicines Canada (IMC)
Pamela Fralick, President, IMC
1.30 – 2.00 Session 4: Biomedical Innovation
Sponsored By: Michael Smith Foundation for Health Research & St. Paul’s Foundation/Providence
Innovation at Providence Health Care
Dr. Martin Trotter, Department Head, Dermatopathologist, St. Paul’s Hospital
“Traversing the pathway from concept to implementation: a PROOF case study”
Introduction: Dr. Bev Holmes, President & CEO, Michael Smith Foundation for Health Research (MSFHR)
Moderator: Dr. Bruce McManus, Professor Department of Pathology and Laboratory Medicine, UBC
Panellists:
- Dr. Ji-Young Kim, Assay Development Scientist, PROOF Centre of Excellence
- Dr. Leslie Grad, Manager, Research Programs, MSFHR
- Dr. David Granville, Professor, Department of Pathology & Laboratory Medicine, University of British Columbia
- Dr. Samuel Wadsworth, Co-Founder & CSO, Aspect Biosystems Inc.
2.00 – 2.30 Session 5: The Innovation Imperative – Where Are We Now
Introduction: Thomas O’Shaughnessy, Partner, Western Leader Health Care, Deloitte Canada
Speaker: Mike Standing, Regional Leader, Life Sciences & Health Care, Europe, Middle East and Africa (EMEA), Deloitte
2.30 – 3.20 Session 6: Pharmacogenomics
Sponsored By: Genome BC
Panel Moderator: Dr. Ellie Griffith, Sector Director, Health, Genome BC
Panellists:
- Dr. Jehannine Austin, Professor, Psychiatry & Medical Genetics, University of British Columbia
- Carolyn Bell, Executive Director, BC Ministry of Health
- Dr. Catalina Lopez-Correa, CSO, Vice President, Sectors, Genome BC
- Dr. Daniel Mueller, Clinician Scientist & Head, Pharmacogenomics Research Clinic, Campbell Family Mental Health Research Institute
- Geraldine Vance, CEO, BC Pharmacy Association
3.20 – 3.40 Networking Break Sponsored By: Innovative Medicines Canada
3.40 – 4.20 Session 7: Innovating and Growing Our Companies
Sponsored By: Accel-Rx
Moderator: Elayne Wandler, Director, Partnerships & Program, Accel-Rx
Panellists:
- Christine Charette, Managing Director and Founder, Scientia Advisors
- Robert Dawson, Director, Access and Government Relations, Pfizer Canada Inc.
- Dr. Simon Pimstone, CEO, Xenon Pharmaceuticals
- Allyson Tighe, Co-founder and Associate, Amplitude Ventures
4.20 – 4.50 Session 8: New Perspectives on Privacy/Security of Data in Health Sponsored By: Roche Canada
Moderator Dr. Martin Ester, Professor, Computing Science, Simon Fraser University
Panellists:
- Praveen Gupta, CEO, PHEMI
- Scott Morrison, CTO, PHEMI
- Dvorah Richler, Senior Manager, Strategic Partnerships and Policy, Personalized Health Care, Hoffmann-La Roche Limited
4.50 – 5.30 Session 9: Being Bold in Our Innovation
Sponsored By: Zymeworks
Moderator: Dr. Ali Tehrani, Founder, President & CEO, Zymeworks
- Vern Brownell, President & CEO, D-Wave Systems
- Dr. Carl Hansen, CEO, AbCellera
- Tamer Mohamed, Co-Founder, President & CEO, Aspect Biosystems
5.30 – 5.40 Closing Remarks
Ali Ardakani, Vice-Chair, Board of Directors, LifeSciences BC & Founder & Managing Director, Novateur Ventures
5.40 – 7.00 Networking Reception